© Boston Life Sciences. 2012. All rights reserved. Important Legal Notice

Breaking News: Boston Life Sciences, Inc. Elects William L.S. Guinness to Its Board of Directors. more >

Boston Life Sciences Ends ALTROPANE(R) POET-1 Phase III Trial Early to Evaluate Full Data Set. more >

Boston Life Sciences Moves into New Headquarters. more >

Boston Life Sciences Announces $12.7 Million Private Placement of Common Stock. more >

Press Inquiries:

Boston Life Sciences, Inc. is a Biotechnology Company Engaged in the Research and Clinical Development of Novel Diagnostic and Therapeutic Products for Central Nervous System Diseases.